We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA issued a Class I recall March 3 for Gambro Renal’s Prisma continuous renal replacement system CRRT, following a flurry of serious complaints associated with the device, including 11 injuries and nine deaths.